Search research articles
Contact Us
Filters
Showing results (71-80 of 74) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 74 results.
American Journal of Hematology
|
January 12, 1999
Evidence for involvement of tumor necrosis factor-alpha in apoptotic death of bone marrow cells in myelodysplastic syndromes
S D Mundle, A Ali, J D Cartlidge, et al.
British Journal of Haematology
|
February 19, 2002
Increased incidence of mitochondrial cytochrome c-oxidase gene mutations in patients with myelodysplastic syndromes
Poluru L Reddy, Vilasini T Shetty, Diya Dutt, et al.
Blood
|
October 1, 1996
Indication of an involvement of interleukin-1 beta converting enzyme-like protease in intramedullary apoptotic cell death in the bone marrow of patients with myelodysplastic syndromes
S D Mundle, P Venugopal, J D Cartlidge, et al.
Experimental Hematology
|
June 1, 1997
Cell cycle kinetic studies in 68 patients with myelodysplastic syndromes following intravenous iodo- and/or bromodeoxyuridine
A Raza, S Alvi, L Broady-Robinson, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 74) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 74 results.
American Journal of Hematology
|
January 12, 1999
Evidence for involvement of tumor necrosis factor-alpha in apoptotic death of bone marrow cells in myelodysplastic syndromes
S D Mundle, A Ali, J D Cartlidge, et al.
British Journal of Haematology
|
February 19, 2002
Increased incidence of mitochondrial cytochrome c-oxidase gene mutations in patients with myelodysplastic syndromes
Poluru L Reddy, Vilasini T Shetty, Diya Dutt, et al.
Blood
|
October 1, 1996
Indication of an involvement of interleukin-1 beta converting enzyme-like protease in intramedullary apoptotic cell death in the bone marrow of patients with myelodysplastic syndromes
S D Mundle, P Venugopal, J D Cartlidge, et al.
Experimental Hematology
|
June 1, 1997
Cell cycle kinetic studies in 68 patients with myelodysplastic syndromes following intravenous iodo- and/or bromodeoxyuridine
A Raza, S Alvi, L Broady-Robinson, et al.
Page
of 8